Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity

Lee A. Dawson, Zoë A. Hughes, Kathryn R. Starr, James D. Storey, Letizia Bettelini, Fabrizio Bacchi, Roberto Arban, Alessandro Poffe, Sergio Melotto, J.J. Hagan,

Neuropharmacology · 2006 · 40 citations · 40 references

Concepts

References

40